ProShare Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $566K | Sell |
|
|||||
|
2025
Q1 | $537K | Sell |
|
|||||
|
2024
Q4 | $658K | Buy |
|
|||||
|
2024
Q3 | $466K | Buy |
|
|||||
|
2024
Q2 | $312K | Sell |
|
|||||
|
2024
Q1 | $338K | Buy |
|
|||||
|
2023
Q4 | $305K | Buy |
|
|||||
|
2023
Q3 | $220K | Sell |
|
|||||
|
2023
Q2 | $268K | Buy |
|
|||||
|
2023
Q1 | $250K | Sell |
|
|||||
|
2022
Q4 | $255K | Sell |
|
|||||
|
2022
Q3 | $304K | Buy |
|
|||||
|
2022
Q2 | $311K | Sell |
|
|||||
|
2022
Q1 | $580K | Sell |
|
|||||
|
2021
Q4 | $953K | Buy |
|
|||||
|
2021
Q3 | $826K | Sell |
|
|||||
|
2021
Q2 | $1.07M | Buy |
|
|||||
|
2021
Q1 | $1.13M | Buy |
|
|||||
|
2020
Q4 | $689K | Buy |
|
|||||
|
2020
Q3 | $519K | Sell |
|
|||||
|
2020
Q2 | $625K | Buy |
|
|||||
|
2020
Q1 | $295K | Sell |
|
|||||
|
2019
Q4 | $793K | Sell |
|
|||||
|
2019
Q3 | $865K | Sell |
|
|||||
|
2019
Q2 | $1.14M | Sell |
|
|||||
|
2019
Q1 | $1.47M | Buy |
|
|||||
|
2018
Q4 | $1.55M | Sell |
|
|||||
|
2018
Q3 | $3.42M | Sell |
|
|||||
|
2018
Q2 | $2.67M | Sell |
|
|||||
|
2018
Q1 | $2.24M | Sell |
|
|||||
|
2017
Q4 | $2.14M | Buy |
|
|||||
|
2017
Q3 | $1.93M | Buy |
|
|||||
|
2017
Q2 | $1.61M | Sell |
|
|||||
|
2017
Q1 | $1.5M | Sell |
|
|||||
|
2016
Q4 | $1.78M | Buy |
|
|||||
|
2016
Q3 | $1.63M | Sell |
|
|||||
|
2016
Q2 | $2.18M | Buy |
|
|||||
|
2016
Q1 | $1.92M | Sell |
|
|||||
|
2015
Q4 | $2.06M | Buy |
|
|||||
|
2015
Q3 | $1.47M | Sell |
|
|||||
|
2015
Q2 | $1.84M | Sell |
|
|||||
|
2015
Q1 | $1.55M | Buy |
|
|||||
|
2014
Q4 | $955K | Sell |
|
|||||
|
2014
Q3 | $913K | Sell |
|
|||||
|
2014
Q2 | $1.47M | Sell |
|
|||||
|
2014
Q1 | $2.31M | Buy |
|
|||||
|
2013
Q4 | $552K | Sell |
|
|||||
|
2013
Q3 | $798K | Buy |
|
|||||
|
2013
Q2 | $568K | Buy |
|